Adjuvant BCG immunotherapy for stage I and II malignant melanoma.

Initial adjuvant immunotherapy trials have demonstrated a greater disease-free interval in patients treated with bacille Calmette-Guérin (BCG) compared with historical controls. In this study 149 patients at high risk of recurrence after surgical treatment of local or regional malignant melanoma wer...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Silver, H. K., Ibrahim, E. M., Evers, J. A., Thomas, J. W., Murray, R. N., Spinelli, J. J.
Format: Artigo
Jezik:Inglês
Izdano: 1983
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1874918/
https://ncbi.nlm.nih.gov/pubmed/6342739
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki